Tony Wood, GSK CSO
Exclusive: GSK revamps its research strategy, building three teams to target specific disease spaces
GSK is shaking up the way it does research and created three unique teams zeroing in on vaccines and infectious diseases, respiratory and immunology, and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.